Sen. Sanders Calls on Trump to Rescind Pharma Giveaway of Potential Coronavirus Treatment
March 26, 2020
March 26, 2020
WASHINGTON, March 26 -- Sen. Bernie Sanders, I-Vermont, issued the following statement:
Reacting to the decision by the Trump Administration's FDA to grant Gilead Sciences a seven-year monopoly for antiviral medication remdesivir for potential treatment of the coronavirus, Sen. Bernie Sanders (I-Vt.) issued the following statement:
"It is truly outrageous that after taxpayers put tens of millions of dollars into developing remdesivir, Trump's FDA is exploiting a l . . .
Reacting to the decision by the Trump Administration's FDA to grant Gilead Sciences a seven-year monopoly for antiviral medication remdesivir for potential treatment of the coronavirus, Sen. Bernie Sanders (I-Vt.) issued the following statement:
"It is truly outrageous that after taxpayers put tens of millions of dollars into developing remdesivir, Trump's FDA is exploiting a l . . .